| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.4 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |